CDSCO panel waives Phase 3 trials for generic HIV prevention drug lenacapavir
An expert panel under India's drug regulator has recommended waiving local Phase 3 clinical trials for generic versions of lenacapavir, a twice-yearly injectable drug for HIV prevention. The Subject Expert Committee on…
